Login to Your Account

Study suggests orphan drug legislation might be too successful

By Nuala Moran
Staff Writer

Friday, October 28, 2016

LONDON – A study by U.K. academics shows that orphan drug legislation designed to incentivize investment in treatments for rare diseases is generating products so profitable that investment in broader indications is being stifled.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription